To determine whether PRDX2 up-regulation in colorectal cancer cell lines could clinically correlate with CRC progression, Western blotting and qRT-PCR analysis were done in six matched colorectal cancer lesions and noncancerous tissues adjacent to colorectal cancer lesions. The gene discussed is PRDX2; the disease is colorectal carcinoma.